Aurora a kinase activity influences calcium signaling in kidney cells

Journal of Cell Biology

Volumn 193, Issue 6, 2011, Pages 1021-1032

  Plotnikova, Olga V ^a   Golemis, Erica A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CALCIUM ION; CATION CHANNEL; POLYCYSTIN 1; POLYCYSTIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CELL ACTIVATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE; GENE MUTATION; GENETIC CODE; KIDNEY CELL; KIDNEY CYST; KIDNEY PARENCHYMA; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PKD1 GENE; PKD2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM; CALCIUM SIGNALING; HEK293 CELLS; HUMANS; KIDNEY; MICE; POLYCYSTIC KIDNEY DISEASES; PROTEIN-SERINE-THREONINE KINASES; TRPP CATION CHANNELS;

EID: 79959410384     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201012061     Document Type: Article

References (67)

1. Anand, S., S. Penrhyn-Lowe, and A.R. Venkitaraman. 2003. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell. 3:51-62.
2. Anyatonwu, G.I., and B.E. Ehrlich. 2004. Calcium signaling and polycystin-2. Biochem. Biophys. Res. Commun. 322:1364-1373.
3. Bacallao, R.L., and H. McNeill. 2009. Cystic kidney diseases and planar cell polarity signaling. Clin. Genet. 75:107-117.
4. Battini, L., S. Macip, E. Fedorova, S. Dikman, S. Somlo, C. Montagna, and G.L. Gusella. 2008. Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum. Mol. Genet. 17:2819-2833.
5. Bayliss, R., T. Sardon, I. Vernos, and E. Conti. 2003. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell. 12:851-862.
6. Benzing, T., and G. Walz. 2006. Cilium-generated signaling: a cellular GPS? Curr. Opin. Nephrol. Hypertens. 15:245-249.
7. Bischoff, J.R., L. Anderson, Y. Zhu, K. Mossie, L. Ng, B. Souza, B. Schryver, P. Flanagan, F. Clairvoyant, C. Ginther, et al. 1998. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17:3052-3065.
8. Burtey, S., M. Riera, E. Ribe, P. Pennenkamp, R. Rance, J. Luciani, B. Dworniczak, M.G. Mattei, and M. Fontés. 2008. Centrosome overduplication and mitotic instability in PKD2 transgenic lines. Cell Biol. Int. 32:1193-1198.
9. Cai, Y., Y. Maeda, A. Cedzich, V.E. Torres, G. Wu, T. Hayashi, T. Mochizuki, J.H. Park, R. Witzgall, and S. Somlo. 1999. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 274:28557- 28565.
10. Cai, Y., G. Anyatonwu, D. Okuhara, K.B. Lee, Z. Yu, T. Onoe, C.L. Mei, Q. Qian, L. Geng, R. Wiztgall, et al. 2004. Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J. Biol. Chem. 279:19987-19995.
11. Clough, R.R., R.S. Sidhu, and R.P. Bhullar. 2002. Calmodulin binds RalA and RalB and is required for the thrombin-induced activation of Ral in human platelets. J. Biol. Chem. 277:28972-28980.
12. Ferchichi, I., N. Stambouli, R. Marrackchi, Y. Arlot, C. Prigent, A. Fadiel, K. Odunsi, A. Ben Ammar Elgaaied, and A. Hamza. 2010. Experimental and computational studies indicate specific binding of pVHL protein to Aurora-A kinase. J. Phys. Chem. B. 114:1486-1497.
13. Ferrari, S., O. Marin, M.A. Pagano, F. Meggio, D. Hess, M. El-Shemerly, A. Krystyniak, and L.A. Pinna. 2005. Aurora-A site specificity: a study with synthetic peptide substrates. Biochem. J. 390:293-302.
14. Fischer, E., E. Legue, A. Doyen, F. Nato, J.F. Nicolas, V. Torres, M. Yaniv, and M. Pontoglio. 2006. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38:21-23.
15. Foggensteiner, L., A.P. Bevan, R. Thomas, N. Coleman, C. Boulter, J. Bradley, O. Ibraghimov-Beskrovnaya, K. Klinger, and R. Sandford. 2000. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J. Am. Soc. Nephrol. 11:814-827.
16. Gattone, V.H. II, N.X. Chen, R.M. Sinders, M.F. Seifert, D. Duan, D. Martin, C. Henley, and S.M. Moe. 2009. Calcimimetic inhibits late-stage cyst growth in ADPKD. J. Am. Soc. Nephrol. 20:1527-1532.
17. Gautschi, O., J. Heighway, P.C. Mack, P.R. Purnell, P.N. Lara Jr., and D.R. Gandara. 2008. Aurora kinases as anticancer drug targets. Clin. Cancer Res. 14:1639-1648.
18. Geng, L., C.R. Burrow, H.P. Li, and P.D. Wilson. 2000. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim. Biophys. Acta. 1535:21-35.
19. Geng, L., W. Boehmerle, Y. Maeda, D.Y. Okuhara, X. Tian, Z. Yu, C.U. Choe, G.I. Anyatonwu, B.E. Ehrlich, and S. Somlo. 2008. Syntaxin 5 regulates the endoplasmic reticulum channel-release properties of polycystin-2. Proc. Natl. Acad. Sci. USA. 105:15920-15925.
20. Giamarchi, A., F. Padilla, B. Coste, M. Raoux, M. Crest, E. Honoré, and P. Delmas. 2006. The versatile nature of the calcium-permeable cation channel TRPP2. EMBO Rep. 7:787-793.
21. Goepfert, T.M., Y.E. Adigun, L. Zhong, J. Gay, D. Medina, and W.R. Brinkley. 2002. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res. 62:4115-4122.
22. Grimm, D.H., Y. Cai, V. Chauvet, V. Rajendran, R. Zeltner, L. Geng, E.D. Avner, W. Sweeney, S. Somlo, and M.J. Caplan. 2003. Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells. J. Biol. Chem. 278:36786-36793.
23. Hanaoka, K., F. Qian, A. Boletta, A.K. Bhunia, K. Piontek, L. Tsiokas, V.P. Sukhatme, W.B. Guggino, and G.G. Germino. 2000. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature. 408:990-994.
24. Harrell, F.E., Jr. 2001. Chapter 2. In Regression Modeling Strategies: with applications to linear models, logistic regression, and survival analysis. F.E. Harrell Jr., editor. Springer, New York. 11-40.
25. Harris, P.C., and V.E. Torres. 2009. Polycystic kidney disease. Annu. Rev. Med. 60:321-337.
26. Hutterer, A., D. Berdnik, F. Wirtz-Peitz, M. Zigman, A. Schleiffer, and J.A. Knoblich. 2006. Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev. Cell. 11:147-157.
27. Köttgen, M., T. Benzing, T. Simmen, R. Tauber, B. Buchholz, S. Feliciangeli, T.B. Huber, B. Schermer, A. Kramer-Zucker, K. Höpker, et al. 2005. Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J. 24:705-716.
28. Koulen, P., Y. Cai, L. Geng, Y. Maeda, S. Nishimura, R. Witzgall, B.E. Ehrlich, and S. Somlo. 2002. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4:191-197.
29. Kurahashi, T., H. Miyake, I. Hara, and M. Fujisawa. 2007. Significance of Aurora-A expression in renal cell carcinoma. Urol. Oncol. 25:128-133.
30. Law, S.F., J. Estojak, B. Wang, T. Mysliwiec, G.D. Kruh, and E.A. Golemis. 1996. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:3327-3337.
31. Law, S.F., Y.-Z. Zhang, A.J. Klein-Szanto, and E.A. Golemis. 1998. Cell cycleregulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments. Mol. Cell. Biol. 18: 3540-3551.
32. Law, S.F., Y.-Z. Zhang, S.J. Fashena, G. Toby, J. Estojak, and E.A. Golemis. 1999. Dimerization of the docking/adaptor protein HEF1 via a carboxyterminal helix-loop-helix domain. Exp. Cell Res. 252:224-235.
33. Li, X., Y. Luo, P.G. Starremans, C.A. McNamara, Y. Pei, and J. Zhou. 2005. Polycystin-1 and polycystin-2 regulate the cell cycle through the helixloop-helix inhibitor Id2. Nat. Cell Biol. 7:1202-1212.
34. Loghman-Adham, M., S.M. Nauli, C.E. Soto, B. Kariuki, and J. Zhou. 2003. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts. Am. J. Physiol. Renal Physiol. 285:F397-F412.
35. Marumoto, T., D. Zhang, and H. Saya. 2005. Aurora-A - a guardian of poles. Nat. Rev. Cancer. 5:42-50.
36. Meraldi, P., R. Honda, and E.A. Nigg. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 21:483-492.
37. Mori, D., M. Yamada, Y. Mimori-Kiyosue, Y. Shirai, A. Suzuki, S. Ohno, H. Saya, A. Wynshaw-Boris, and S. Hirotsune. 2009. An essential role of the aPKCAurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics. Nat. Cell Biol. 11:1057-1068.
38. Nauli, S.M., F.J. Alenghat, Y. Luo, E. Williams, P. Vassilev, X. Li, A.E. Elia, W. Lu, E.M. Brown, S.J. Quinn, et al. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33:129-137.
39. Ogawa, H., N. Ohta, W. Moon, and F. Matsuzaki. 2009. Protein phosphatase 2A negatively regulates aPKC signaling by modulating phosphorylation of Par-6 in Drosophila neuroblast asymmetric divisions. J. Cell Sci. 122:3242-3249.
40. O'Neill, G.M., and E.A. Golemis. 2001. Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics. Mol. Cell. Biol. 21:5094- 5108.
41. Pan, J., Q. Wang, and W.J. Snell. 2004. An aurora kinase is essential for flagellar disassembly in Chlamydomonas. Dev. Cell. 6:445-451.
42. Pan, J., Q. Wang, and W.J. Snell. 2005. Cilium-generated signaling and cilia-related disorders. Lab. Invest. 85:452-463.
43. Plotnikova, O.V., E.N. Pugacheva, R.L. Dunbrack, and E.A. Golemis. 2010. Rapid calcium-dependent activation of Aurora-A kinase. Nat Commun. 1:64.
44. Pugacheva, E.N., and E.A. Golemis. 2005. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat. Cell Biol. 7:937-946.
45. Pugacheva, E.N., and E.A. Golemis. 2006. HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks. Cell Cycle. 5:384-391.
46. Pugacheva, E.N., S.A. Jablonski, T.R. Hartman, E.P. Henske, and E.A. Golemis. 2007. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 129:1351-1363.
47. Qian, Q., L.W. Hunter, M. Li, M. Marin-Padilla, Y.S. Prakash, S. Somlo, P.C. Harris, V.E. Torres, and G.C. Sieck. 2003. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum. Mol. Genet. 12:1875-1880.
48. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer. 8:361-375.
49. Ryan, M.J., G. Johnson, J. Kirk, S.M. Fuerstenberg, R.A. Zager, and B. Torok-Storb. 1994. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48-57.
50. Singh, M., L. Cowell, S. Seo, G. O'Neill, and E. Golemis. 2007. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem. Biophys. 48:54-72.
51. Singh, M.K., D. Dadke, E. Nicolas, I.G. Serebriiskii, S. Apostolou, A. Canutescu, B.L. Egleston, and E.A. Golemis. 2008. A novel Cas family member, HEPL, regulates FAK and cell spreading. Mol. Biol. Cell. 19:1627-1636.
52. Skobeleva, N., S. Menon, L. Weber, E.A. Golemis, and V. Khazak. 2007. In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors. Mol. Cancer Ther. 6:898-906.
53. Sneppen, K., S. Krishna, and S. Semsey. 2010. Simplified models of biological networks. Annu Rev Biophys. 39:43-59.
54. Soncini, C., P. Carpinelli, L. Gianellini, D. Fancelli, P. Vianello, L. Rusconi, P. Storici, P. Zugnoni, E. Pesenti, V. Croci, et al. 2006. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clin. Cancer Res. 12:4080-4089.
55. Streets, A.J., D.J. Moon, M.E. Kane, T. Obara, and A.C. Ong. 2006. Identification of an N-terminal glycogen synthase kinase 3 phosphorylation site which regulates the functional localization of polycystin-2 in vivo and in vitro. Hum. Mol. Genet. 15:1465-1473.
56. Streets, A.J., A.J. Needham, S.K. Gill, and A.C. Ong. 2010. Protein kinase D-mediated phosphorylation of polycystin-2 (TRPP2) is essential for its effects on cell growth and calcium channel activity. Mol. Biol. Cell. 21:3853-3865.
57. Sweeney, W.E. Jr., R.O. von Vigier, P. Frost, and E.D. Avner. 2008. Src inhibition ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 19:1331- 1341.
58. Tanaka, T., M. Kimura, K. Matsunaga, D. Fukada, H. Mori, and Y. Okano. 1999. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 59:2041-2044.
59. Tanner, M.M., S. Grenman, A. Koul, O. Johannsson, P. Meltzer, T. Pejovic, A. Borg, and J.J. Isola. 2000. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6:1833-1839.
60. Tatsuka, M., H. Katayama, T. Ota, T. Tanaka, S. Odashima, F. Suzuki, and Y. Terada. 1998. Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 58:4811-4816.
61. Wilson, P.D. 2004. Polycystic kidney disease. N. Engl. J. Med. 350:151-164.
62. Wong, S.Y., A.D. Seol, P.L. So, A.N. Ermilov, C.K. Bichakjian, E.H. Epstein Jr., A.A. Dlugosz, and J.F. Reiter. 2009. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat. Med. 15:1055-1061.
63. Wu, J.C., T.Y. Chen, C.T. Yu, S.J. Tsai, J.M. Hsu, M.J. Tang, C.K. Chou, W.J. Lin, C.J. Yuan, and C.Y. Huang. 2005. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J. Biol. Chem. 280:9013-9022.
64. Xu, J., H. Li, B. Wang, Y. Xu, J. Yang, X. Zhang, S.K. Harten, D. Shukla, P.H. Maxwell, D. Pei, and M.A. Esteban. 2010. VHL inactivation induces HEF1 and Aurora kinase A. J. Am. Soc. Nephrol. 21:2041-2046.
65. Yamada, M., S. Hirotsune, and A. Wynshaw-Boris. 2010. The essential role of LIS1, NDEL1 and Aurora-A in polarity formation and microtubule organization during neurogensis. Cell Adh Migr. 4:180-184.
66. Zhang, D., T. Hirota, T. Marumoto, M. Shimizu, N. Kunitoku, T. Sasayama, Y. Arima, L. Feng, M. Suzuki, M. Takeya, and H. Saya. 2004. Cre-loxPcontrolled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene. 23:8720-8730.
67. Zhou, H., J. Kuang, L. Zhong, W.L. Kuo, J.W. Gray, A. Sahin, B.R. Brinkley, and S. Sen. 1998. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20:189- 193.